Your browser doesn't support javascript.
loading
The complement component C5 is not responsible for the alternative pathway activity in rabbit erythrocyte hemolytic assays during eculizumab treatment.
van den Heuvel, Lambertus P; van de Kar, Nicole C A J; Duineveld, Caroline; Sarlea, Andrei; van der Velden, Thea J A M; Liebrand, Wilhelmus T B; van Kraaij, Sanne; Schjalm, Camilla; Bouwmeester, Romy; Wetzels, Jack F M; Mollnes, Tom E; Volokhina, Elena B.
Afiliação
  • van den Heuvel LP; Department of Pediatric Nephrology Amalia Children's Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • van de Kar NCAJ; Department of Laboratory Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Duineveld C; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium.
  • Sarlea A; Department of Pediatric Nephrology Amalia Children's Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • van der Velden TJAM; Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
  • Liebrand WTB; Department of Pediatric Nephrology Amalia Children's Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • van Kraaij S; Department of Pediatric Nephrology Amalia Children's Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Schjalm C; Department of Pediatric Nephrology Amalia Children's Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Bouwmeester R; Department of Laboratory Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Wetzels JFM; Department of Immunology, Oslo University Hospital and University of Oslo, Oslo, Norway.
  • Mollnes TE; Department of Pediatric Nephrology Amalia Children's Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Volokhina EB; Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Cell Mol Immunol ; 17(6): 653-655, 2020 06.
Article em En | MEDLINE | ID: mdl-32210393
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complemento C5 / Via Alternativa do Complemento / Eritrócitos / Anticorpos Monoclonais Humanizados / Hemólise Limite: Animals / Humans Idioma: En Revista: Cell Mol Immunol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complemento C5 / Via Alternativa do Complemento / Eritrócitos / Anticorpos Monoclonais Humanizados / Hemólise Limite: Animals / Humans Idioma: En Revista: Cell Mol Immunol Ano de publicação: 2020 Tipo de documento: Article